Good afternoon, everybody. I now call the meeting to order.
Pursuant to Standing Order 108(2), a study of the effects of mefloquine use among Canadian veterans, today we have two witnesses appearing as individuals: Dr. Jonathan Douglas, a psychologist with Central Ontario Psychology; and Dr. Penelope Suter, an optometrist. She is on a video conference from Bakersfield, California.
Dr. Suter, welcome. We'll start with your opening statement.